Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Preprint posted online November 1, 2025
WADA Prohibition The World Anti-Doping Agency classification for these peptides: GLP3 likely classified under prohibited substances as a GLP-1 receptor agonist Cagrilintide status as amylin analog may fall under peptide hormone prohibitions Combined formulation would be prohibited under multiple substance categories No Therapeutic Use Exemptions (TUEs) available for either component Detection methods under development for anti-doping testing WADAs position reflects that these remain investigational agents without regulatory approval from health authorities worldwide
Higher concentrations (2.5ml water = 20mg/ml) reduce injection volume but require more precise measurement
Peptide mechanisms can help restore a better hormonal balance, supporting a regular cycle and improving the ovarian reserve, especially for women with low AMH
US$ 27.19
US$ 22.99
US$ 22.43
US$ 29.54
US$ 26.14
US$ 23.11
US$ 25.66
US$ 25.02
